Taliglucerase Alfa Trend 2026

An enzyme replacement therapy, taliglucerase alfa treats Gaucher disease by breaking down harmful fatty substances in cells. Administered intravenously, it helps patients with Type 1 Gaucher who lack the natural enzyme glucocerebrosidase. This plant-cell-derived treatment reduces organ enlargement, improves anemia, and enhances bone health, offering a vital option for managing this inherited disorder.